Baurs partners with GSK for continuous distribution of its medicines and vaccines in Sri Lanka

A. Baur & Co. Ltd., recently entered a partnership for the distribution of the multinational pharmaceutical company GSK’s prescription medicines and vaccines in Sri Lanka.During the latter part of last year, GSK announced its intention to wind down its commercial business in Sri Lanka. With this new alliance, both Baurs and GSK reaffirm their unwavering commitment to the people of the country and ensure patients have uninterrupted access to GSK’s safe, effective and high-quality medications.

In marking the partnership, an event was held on 09th May 2023 at the Lotus Ballroom, Shangri-La Colombo. Baurs Managing Director/CEO Rolf Blaser and GSK Executive Director/Chief Financial Officer and Country Manager, Sri Lanka and Maldives Manoj Jayawardena gave their opening speeches, followed by an official handing over ceremony, together with Baurs Director Healthcare, Nishantha Weerasinghe and Director Baur Life Sciences, Gehan Seneviratne. The event also saw the participation of the board, project teams, and HoDs of both Baurs and GSK Sri Lanka.

Some of the world-class healthcare brands that Baurs represent in Sri Lanka include Sanofi, Novartis, Sandoz, Nestlé Health Science, Merck, Roche, isispharma, MSD, Vitrolife, Unichem, Apex, Alcon, Vaitris, Inova, Santen, Eisai, Mega life Science, Rohto, Dexa Medica, Takeda and Ajanta Pharma among others.